JPX : 4549.T
-$360 (-14.34%)
JPX
Yuji Segawa
Medical - Devices
Healthcare
4549.T
696
JP
JPY
0.14
2.20
1.63
0.68
0.00
$41.9B
1.67
1.63
0.00
0.00
$112.5
$3.71B
8.37%
10.98%
8.11%
5.74%
19.95
0.35
0.35
3/5
0 Analysts
%
4.27
6/9
$17.26B
$61.9B
$18.4B
$4.73B
No key metrics data available.
| Name | Title |
|---|---|
| Katsunori Watanabe | Exec Off, GM of Nogi Plant & Production Div and GM of Nasu Plant & Production Div |
| Keiichiro Yoshida | Executive Officer and General Manager of Global Sales Division & Sales Headquarters |
| Tomohiro Kudo | Exec. Officer, GM of Business Management Headquarters, CFO, CHRO & Director |
| Norihiro Tomita | Executive Officer and GM of Basic Research Laboratory & R&D Division |
| Hiroyasu Furuhashi | Executive Officer & GM of Internal Audit Office |
| Michitoshi Doi | VP, Executive Officer, GM, Production Headquarters, CPO |
| Tsugunori Notomi | Chairman |
| Yuji Segawa | President, CEO, COO & Director |
| Satoshi Akaishi | Executive Officer, GM of Domestic Sales Office & Sales Division and GM of Sales Admin Office |
| Toshiyuki Tsuchitani | Executive Officer, General Manager, Sales Headquarters & CMSO |
| Yasuyoshi Mori | Senior VP, Executive Officer, GM of R&D Headquarters, CTO & Director |
No votes yet today — be the first to share your view!
About Eiken Chemical Co., Ltd. (JPX:4549.T) Stock
Eiken Chemical Co., Ltd. is a Japanese manufacturer and distributor specializing in clinical diagnostic products and medical equipment. The company excels in developing diagnostic solutions for diverse medical fields, encompassing biochemical analysis, immunology, serology, dry chemical assays, and automated diagnostic systems. A significant offering is the OC-SENSOR, an automated immunochemical fecal test designed to identify gastrointestinal bleeding linked to conditions such as colorectal cancer, polyps, and diverticulitis. Its comprehensive product portfolio further includes real-time turbidimeters, temperature-controlled equipment, various amplification and fluorescence detection reagents for research applications, and general detection kits. Eiken Chemical also produces a variety of ... microbiology-related products, alongside additional immunological and serological reagents. Established in Tokyo, Japan, in 1939, the company initially operated as Nihon Eiyokagaku Co., Ltd. until its rebranding to Eiken Chemical Co., Ltd. in 1969.
Frequently Asked Questions
What is the current Eiken Chemical Co., Ltd. (4549.T) stock price?
Eiken Chemical Co., Ltd.(JPX:4549.T) stock price is $2151 in the last trading session. During the trading session, 4549.T stock reached the peak price of $3500 while $2151 was the lowest point it dropped to. The percentage change in 4549.T stock occurred in the recent session was --14.34% while the dollar amount for the price change in 4549.T stock was -$360.
4549.T's industry and sector of operation?
The JPX listed 4549.T is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of 4549.T?
Katsunori Watanabe
| Exec Off, GM of Nogi Plant & Production Div and GM of Nasu Plant & Production Div
Keiichiro Yoshida
| Executive Officer and General Manager of Global Sales Division & Sales Headquarters
Tomohiro Kudo
| Exec. Officer, GM of Business Management Headquarters, CFO, CHRO & Director
Norihiro Tomita
| Executive Officer and GM of Basic Research Laboratory & R&D Division
Hiroyasu Furuhashi
| Executive Officer & GM of Internal Audit Office
How many employees does 4549.T have?
Number of 4549.T employees currently stands at 696. 4549.T operates from 4-19-9 Taito, Tokyo, TY 110-8408, JP.
Link for 4549.T official website?
Official Website of 4549.T is: https://www.eiken.co.jp
How do I contact 4549.T?
4549.T could be contacted at phone #81 3 5846 3305 and can also be accessed through its website. 4549.T operates from 4-19-9 Taito, Tokyo, TY 110-8408, JP.
How many shares of 4549.T are traded daily?
The average number of 4549.T shares traded daily for last 3 months was 202.34K.
What is the market cap of 4549.T currently?
The market value of 4549.T currently stands at $70.91B with its latest stock price at $2151